Philip Morris Worldwide Inc. (PMI) to Webcast on Sustainability and Impression for Firm’s Subsequent Progress Section | Corporations

NEW YORK – (BUSINESS WIRE) – Nov. June 2021–

Regulatory News:

Philip Morris International Inc. (NYSE: PM) Chief Executive Officer Jacek Olczak, Chief Financial Officer Emmanuel Babeau and Chief Sustainability Officer Jennifer Motles will host a webcast presentation today on sustainability and implications for the company’s next phase of growth, the The topic of the latest Investor Day. At the Q&A session, Dr. Moira Gilchrist, Vice President, Strategic & Scientific Communications, will attend.

“We are very excited to host our first webcast on ESG performance and sustainability strategy,” said Jacek Olczak, Chief Executive Officer. “Sustainability is at the core of the transformation of our company, which is based on a deep sense of creating value for our shareholders and other stakeholders.”

“Our priority is to consider the health effects of our products and to put them at the center of our sustainability efforts, our 2025 ambitions and our commitment to quitting smoking,” continued Jacek. “But we also strive for excellence in traditional ESG areas. In this context, we are proud to announce that we will now achieve our goal of CO2 neutrality of Scope 1 and 2 for 2030 five years ahead of schedule. “

Webcast details

The presentation and question-and-answer session will be held in a virtual format from approximately 9:00 a.m. Eastern Time. A live video webcast of the entire PMI session will be available in audio-only mode at www.pmi.com/2021esg. Presentation slides will be available on the same website.

An archived copy of the webcast will be available through Thursday, July 1, 2021 at www.pmi.com/2021esg. The archived webcast can also be accessed on iOS or Android devices by downloading PMI’s free Investor Relations Mobile Application at www.pmi. com / irapp.

Integrated report 2020

The webcast follows the recent release of PMI’s 2020 Integrated Report, as well as a new section on the PMI website on sustainability. The report provides a comprehensive overview of the company’s approach to ESG issues and its progress towards a smoke-free future. The report also highlights PMI’s top sustainability issues – including the health impact of its products, an aspect often missed by external ESG assessments – and describes how the company is researching and developing science-based better alternatives to adult smoking who don’t. Leaving.

To complement the Integrated Report, PMI has also created an ESG Highlights Document that summarizes the report in a more data-driven format and provides direct access to indices that support its disclosures internationally recognized frameworks (including GRI, SASB, Sustainable Development Goals (SDGs)) and the measurement of the IBC / WEF’s stakeholder capitalism).

Forward-looking and cautionary statements

This press release contains projections of future results and other forward-looking statements. Achieving future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize or underlying assumptions prove to be incorrect, the actual results may differ materially from those contained in such forward-looking statements. In accordance with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI identifies important factors that, individually or collectively, could cause actual results and results to differ materially from those contained in any forward-looking statements by PMI.

PMI’s business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could affect our competitiveness, affect our ability to communicate with adult consumers, or prohibit certain of our products; health concerns related to the consumption of tobacco and other nicotine-containing products and exposure to tobacco smoke in the environment; Litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual economic, regulatory and political developments, natural disasters and conflicts; Changes in adult smoking behavior; lost revenue from counterfeiting, contraband and cross-border purchases; state investigations; unfavorable exchange rates and currency devaluations and restrictions on repatriation of funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; as well as the integrity of our information systems and the effectiveness of our data protection guidelines. The future profitability of PMI may also be adversely affected if our attempts to manufacture and commercialize Reduced Risk Products (“RRPs”) are unsuccessful or if regulation or taxation does not distinguish between such products and cigarettes; when we are unable to successfully launch new products, promote brand equity, enter new markets or improve our margins through higher prices and productivity gains; if we fail to expand our brand portfolio internally or through acquisitions and the establishment of strategic business relationships; or when we are unable to attract and retain the world’s best talent. Future results are also subject to the lower predictability of the performance of our risk-reduced product category.

The COVID-19 pandemic has created significant social and economic disruptions, resulting in the closure of shops, factories and offices, and production, sales and travel restrictions, all of which will adversely affect our business, operating results, cash flows and finances Position during the pandemic. Our business continuity plans and other safeguards may not be effective to mitigate the effects of the pandemic. Significant risks currently include our decreased ability to convert adult smokers to our MSRP, significant volume decreases in our duty free and certain other key markets, disruptions or delays in our manufacturing and supply chain, increased currency volatility and delays in certain cost savings. , Transformation and restructuring initiatives. Our business could also be affected if key employees or a significant number of employees or business partners are unavailable due to the COVID-19 outbreak. The significant negative impact of COVID-19 on the economic or political conditions in the markets in which we operate could result in changes in the preferences of our adult consumers and a lower demand for our products, especially for our brands in the middle or higher price segment, to lead. A continuation of the pandemic could disrupt our access to credit markets or increase our borrowing costs. Governments may temporarily not be able to focus on developing science-based regulatory frameworks for developing and commercializing RRP, or on enforcing or enforcing regulations that are relevant to our business. In addition, communications about the potential negative impact of using our products on COVID-19 risks can lead to increasingly restrictive regulatory measures for the sale and use of our products, negatively impact demand for our products, and affect adult consumers’ willingness to switch to our EIA and our efforts to advocate the development of science-based regulatory frameworks for the development and commercialization of EIA.

The impact of these risks also depends on factors beyond our knowledge or control, including the duration and severity of the pandemic, its recurrence in our key markets, measures taken to contain its spread and contain its impact on public health, and eventual ones economic consequences of this.

PMI is also subject to other risks that are listed from time to time in its publicly filed documents, including the Form 10-Q for the quarter ended March 31, 2021. PMI cautions that the above list of important factors is not a complete discussion of all potentials Risks and Uncertainties. PMI does not undertake to update any forward-looking statements from time to time, except as part of its disclosure obligations.

Philip Morris International: Enabling a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products for the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders and its own other stakeholders. PMI is a leading international tobacco company that manufactures and sells cigarettes, as well as smoke-free products, related electronic devices and accessories, and other nicotine-containing products in markets outside the United States. In addition, PMI is supplying versions of its IQOS Platform 1 device and consumables to Altria Group, Inc. for sale under license in the US, where these products are approved by the US Food and Drug Administration (FDA) as part of the premarket tobacco industry. Product Application Pathways (PMTA) have received marketing authorization; The FDA has also cleared the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP) and has determined that an exposure change order for these products to promote public health is appropriate. PMI is building a future with a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary product development skills, state-of-the-art facilities, and scientific backing, PMI aims to ensure that its smoke-free products meet adult consumer preferences and stringent government requirements. PMI’s smoke-free product portfolio includes heat-resistant and nicotine-containing vapor products. PMI’s smoke-free products will be available for sale in 66 markets in major cities or across the country by March 2021, and PMI estimates that approximately 14.0 million adults worldwide have already switched to IQOS and have quit smoking. Further information is available at www.pmi.com and www.pmiscience.com.

View source version on businesswire.com: https: //www.businesswire.com/news/home/20210602005587/en/

CONTACT: Philip Morris International

Investor Relations:

New York: +1 (917) 663 2233

Lausanne: +41 (0) 58 242 4666

InvestorRelations@pmi.comMedia:

Lausanne: +41 (0) 58 242 4500

Iro.Antoniadou@pmi.com

KEYWORD: NEW YORK UNITED STATES NORTH AMERICA CANADA

INDUSTRY KEYWORD: ENVIRONMENT OTHER PHILANTHROPY RETAIL TOBACCO PHILANTHROPY

SOURCE: Philip Morris International

Copyright Business Wire 2021.

PUB: 02.06.2021 08:00 / DISC: 02.06.2021 08: 0303

http://www.businesswire.com/news/home/20210602005587/en